Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron (Q44667127)
Jump to navigation
Jump to search
scientific article published in December 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron |
scientific article published in December 2003 |
Statements
1 reference
Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron (English)
1 reference
Peter Eisenberg
1 reference
Jazmin Figueroa-Vadillo
1 reference
Rosalio Zamora
1 reference
Veena Charu
1 reference
Julio Hajdenberg
1 reference
Alan Cartmell
1 reference
Alberto Macciocchi
1 reference
Steven Grunberg
1 reference
99-04 Palonosetron Study Group
1 reference
1 December 2003
1 reference
Identifiers
1 reference